Add to a list

Inactive Instrument

Pacific Software, Inc. Stock Other OTC

PFSF

US69482P2056

Biotechnology & Medical Research

OTC Markets Traded

Valuation: Pacific Software, Inc.

Market Cap	48.82M 42.68M 39.22M 36.56M 69.35M 4.65B 70.4M 471M 183M 2.29B 183M 179M 7.87B	P/E 2019	-2.65x	P/E 2020	-41.2x
Enterprise Value	49.19M 43M 39.52M 36.84M 69.87M 4.68B 70.93M 474M 184M 2.3B 185M 181M 7.93B	EV / Sales 2019	-	EV / Sales 2020	2,435,972,350x
Free-Float	99%	Yield 2019 *	-	Yield 2020	-

* Estimated data More valuation ratios

Latest news : Pacific Software, Inc.

06-10	Purminds Enterprises, Inc. Announces CFO Changes	CI
06-10	PurMinds Enterprises, Inc. Announces Appointment of Angelo Pizzuto as Chief Operating Officer, Secretary, and Treasurer, Effective June 10, 2026	CI
11-11	Pacific Software Inc Announces Exclusive Partnership with SpectroChip Global Inc	CI
11-10	Pacific Software, Inc. acquired 10763942 Canada Inc. and PurMinds Asset Portfolio from PurMinds NeuroPharma Inc.	CI
25-08-26	Pacific Software, Inc. agreed to acquire 10763942 Canada Inc. and PurMinds Asset Portfolio from PurMinds NeuroPharma Inc.	CI
24-07-22	Robert Schiestl Joins Pacific Software Inc. as Chief Science Advisor	CI
24-05-05	Pacific Software, Inc. acquired Certain assets of Dreamaderm Inc. from Dreamaderm Inc.	CI
21-01-24	Pacific Software, Inc. Reports Earnings Results for the Full Year Ended September 30, 2020	CI
20-12-16	Pacific Software, Inc. Reports Earnings Results for the Full Year Ended September 30, 2019	CI
20-12-16	Pacific Software, Inc. Reports Earnings Results for the Second Quarter Ended March 31, 2020	CI
19-06-18	Pacific Software, Inc. Reports Earnings Results for the Full Year Ended September 30, 2018	CI
19-06-06	Pacific Software Inc. Enters into Memorandum of Understanding with Império Assessoria em Informaçoes LTDA	CI
19-05-12	Pacific Software, Inc. completed the spin-off of Hypersoft Ventures.	CI

More news

Press Releases: Pacific Software, Inc.

01-19	Pacific Software, Inc. Announces Completion of Change of Control with PurMinds Holdings Inc.; Confirms Occupancy of a GMP Production Facility; and OTCQX Uplisting Strategy	PR
11-11	Pacific Software Inc Announces Exclusive Partnership with SpectroChip Global	PR
25-08-27	Pacific Software Inc Acquires 10763942 Canada, Inc. from PurMinds Holdings Inc., Including its PurMinds Products and Research Partners	AQ
24-07-22	Professor Dr. Robert Schiestl Ph. D. Joins Pacific Software Inc. as Chief Science Advisor (CSA)	GL
24-06-28	Pacific Software Inc. Obtaining Quotes for the Manufacturing Cycle for Scientifically Tested Medical Food Cocktail Focused on Memory Health	GL

More press releases

Managers and Directors: Pacific Software, Inc.

Manager	Title	Age	Since
Janet Qi CEO	Chief Executive Officer	-	-
Angelo Pizzuto DFI	Director of Finance/CFO	-	2026-06-09

Director	Title	Age	Since
Harrysen Mittler CHM	Chairman	74	2016-10-21

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PACIFIC SOFTWARE, INC.	-22.83%	-.--%	-	-	3.44M
LONZA GROUP AG	+1.99%	+8.75%	+5.16%	+11.05%	49.92B
REVOLUTION MEDICINES, INC.	+0.92%	+3.93%	+399.71%	+604.02%	40.23B
IQVIA HOLDINGS INC.	+1.89%	+8.32%	+26.06%	-6.27%	34.55B
BEONE MEDICINES AG	+2.38%	+6.35%	+21.25%	+55.45%	33.09B
CELLTRION, INC.	+3.96%	+10.67%	+8.30%	+37.95%	27.51B
ASCENDIS PHARMA A/S	+2.51%	+5.27%	-	-	17.05B
MEDPACE HOLDINGS, INC.	+2.58%	+5.79%	+73.44%	+135.37%	15.92B
EUROFINS SCIENTIFIC SE	+1.07%	+2.82%	+16.29%	+24.07%	13.86B
IONIS PHARMACEUTICALS, INC.	+3.30%	+0.76%	+90.23%	+93.88%	13.52B
Average	-0.22%	+5.82%	+80.06%	+119.44%	27.3B
Weighted average by Cap.	+2.17%	+6.53%	+90.92%	+136.79%

See all sector performances

PurMinds Enterprises, Inc., formerly Pacific Software, Inc., is a precision neuro-medicine development company pursuing solutions to neurological and psychiatric disorders. The Company's clinical pipeline includes neuroprotective compounds that restore neuronal functions and can address multiple clinical indications with significant unmet patient needs. The Company is focused on a 4P Medicine platform, in strategic partnership with SpectroChip Global Inc., for early detection and intervention of conditions before irreversible damage occurs. The Company operates under a Health Canada issued Controlled Drugs and Substances License. It has developed a pipeline of proprietary formulations and novel small molecules (NCEs). The Company's pipeline includes PUR100 Series and PUR500 Series.

Employees

Sector

Biotechnology & Medical Research

More about the company

Google lets you customize your preferred sources.

Choose MarketScreener

	2019	2020
Net sales	-	0.02 0.02 0.02 0.01 0.03 1.9 0.03 0.19 0.07 0.94 0.08 0.07 3.23
Net income	-21.11M -18.46M -16.96M -15.81M -29.99M -2.01B -30.44M -204M -79.16M -988M -79.25M -77.54M -3.4B	-1.17M -1.03M -943K -879K -1.67M -112M -1.69M -11.33M -4.4M -54.96M -4.41M -4.31M -189M
Net Debt	-101K -87.91K -80.78K -75.3K -143K -9.57M -145K -970K -377K -4.71M -377K -369K -16.22M	367K 321K 295K 275K 522K 34.99M 530K 3.54M 1.38M 17.2M 1.38M 1.35M 59.26M

Pacific Software, Inc. Stock Other OTC

Stocks

PFSF

US69482P2056

Biotechnology & Medical Research

Valuation: Pacific Software, Inc.

Latest news : Pacific Software, Inc.

Press Releases: Pacific Software, Inc.

Quotes and Performance

Managers and Directors: Pacific Software, Inc.

Other Biotechnology & Medical Research

Financials

Company Profile